Kite Pharma
This role leads and supports Japan regulatory strategy and execution for cell and gene therapy products across development and post-approval stages. The position involves preparing and maintaining high-quality regulatory dossiers, managing marketing applications, and serving as a key liaison with global stakeholders and health authorities like the PMDA. The ideal candidate will ensure compliance with Japan-specific requirements and communicate regulatory updates to internal stakeholders.
Headquarters
Santa Monica, California, United States
Company Size
1001-5000 employees
Founded
2009
Kite Pharma is a biotechnology company focused on developing cell therapies to treat cancer, specializing in engineered T‑cell (CAR‑T) approaches. The company advances programs from basic science through clinical trials and commercialization, maintaining an active pipeline of therapies for hematologic and solid tumors. Kite also provides patient resources, treatment center networks, and access programs to support therapy delivery. It operates as part of Gilead Sciences, leveraging global capabilities to accelerate curative cancer treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Kite Pharma.
Kite Pharma didn’t post a salary, so this is our estimate from similar listings.
Senior Director, Regulatory Affairs Strategy - Cell and Gene Therapy
AstraZeneca
Senior Regulatory CMC Strategist (Senior Director)
C0003153479P
Manager, CMC Regulatory Affairs
Regeneron Pharmaceuticals
Manager, RA CMC Group, Regulatory Affairs
AbbVie
Director, Regulatory Affairs - Japan
Insmed Incorporated
Senior Regulatory CMC Strategist (Senior Director)
C0003153479P